Codexis (NASDAQ:CDXS) stock climbed 11% in post-market trading after the company announced it had granted an exclusive global license to Roche (OTCQX:RHHBY) for its newly engineered double-stranded ...
Professor Dongsheng Liu of Tsinghua University, Professor Ziyang Hao of Capital Medical University, and Researcher Yuanchen ...
When cells proliferate, genomic DNA is precisely duplicated once per cell cycle. Abnormalities in this DNA replication process can cause alterations in genomic DNA, promoting cellular ageing, cancer, ...
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an agreement with Roche for an exclusive ...
Oncotarget published "Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 ...
Sequence-specific protein ligations are widely used to produce customized proteins “on demand.” Such chimeric, immobilized, fluorophore-conjugated or segmentally labeled proteins are generated using a ...